chartexchange

MaxCyte Inc (MXCT) (Q3 2026) Earnings Call Highlights: Revenue Surges 49% as Accron Acquisition ...

GuruFocus | Nov 11, 2026 12:09 AM EST

MaxCyte Inc (MXCT) posted strong Q3 2026 revenue growth and unveiled a transformative $151.8 million Accron acquisition expected to accelerate profitability and diversify its customer base. Related Stocks: MXCT ,

Read original article